A Hematology Diagnostics Market (Product Type: Hematology Instruments and Hematology Consumables; and End-user: Diagnostic Laboratories, Hospitals & Clinics

Hematology Diagnostics Market (Product Type: Hematology Instruments and Hematology Consumables; and End-user: Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2023-2031


Hematology Diagnostics Market – Scope of Report

TMR’s report on the global hematology diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global hematology diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hematology diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hematology diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hematology diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hematology diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hematology diagnostics market.

The report delves into the competitive landscape of the global hematology diagnostics market. Key players operating in the global hematology diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hematology diagnostics market profiled in this report.

Key Questions Answered in Global hematology diagnostics Market Report
  • What is the sales/revenue generated by hematology diagnostics across all regions during the forecast period?
  • What are the opportunities in the global hematology diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Hematology Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global hematology diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hematology diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hematology diagnostics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hematology Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hematology Diagnostics Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Hematology Diagnostics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2023–2031
6.3.1. Hematology Instruments
6.3.1.1. Hematology Analyzers
6.3.1.1.1. Fully-automated Hematology Analyzers
6.3.1.1.2. Semi-automated Hematology Analyzers
6.3.1.2. Flow Cytometers
6.3.1.3. Others
6.3.2. Hematology Consumables
6.3.2.1. Reagents
6.3.2.2. Stains
6.3.2.3. Controls & Calibrators
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Hematology Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023–2031
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals & Clinics
7.3.3. Academic Institutes
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Hematology Diagnostics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Hematology Diagnostics Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product Type, 2023–2031
9.3.1. Hematology Instruments
9.3.1.1. Hematology Analyzers
9.3.1.1.1. Fully-automated Hematology Analyzers
9.3.1.1.2. Semi-automated Hematology Analyzers
9.3.1.2. Flow Cytometers
9.3.1.3. Others
9.3.2. Hematology Consumables
9.3.2.1. Reagents
9.3.2.2. Stains
9.3.2.3. Controls & Calibrators
9.3.2.4. Others
9.4. Market Value Forecast, by End-user, 2023–2031
9.4.1. Diagnostic Laboratories
9.4.2. Hospitals & Clinics
9.4.3. Academic Institutes
9.5. Market Value Forecast, by Country, 2023–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Hematology Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2023–2031
10.3.1. Hematology Instruments
10.3.1.1. Hematology Analyzers
10.3.1.1.1. Fully-automated Hematology Analyzers
10.3.1.1.2. Semi-automated Hematology Analyzers
10.3.1.2. Flow Cytometers
10.3.1.3. Others
10.3.2. Hematology Consumables
10.3.2.1. Reagents
10.3.2.2. Stains
10.3.2.3. Controls & Calibrators
10.3.2.4. Others
10.4. Market Value Forecast, by End-user, 2023–2031
10.4.1. Diagnostic Laboratories
10.4.2. Hospitals & Clinics
10.4.3. Academic Institutes
10.4.4. Others
10.5. Market Value Forecast, by Country/Sub-region, 2023–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Hematology Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2023–2031
11.3.1. Hematology Instruments
11.3.1.1. Hematology Analyzers
11.3.1.1.1. Fully-automated Hematology Analyzers
11.3.1.1.2. Semi-automated Hematology Analyzers
11.3.1.2. Flow Cytometers
11.3.1.3. Others
11.3.2. Hematology Consumables
11.3.2.1. Reagents
11.3.2.2. Stains
11.3.2.3. Controls & Calibrators
11.3.2.4. Others
11.4. Market Value Forecast, by End-user, 2023–2031
11.4.1. Diagnostic Laboratories
11.4.2. Hospitals & Clinics
11.4.3. Academic Institutes
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Hematology Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2023–2031
12.3.1. Hematology Instruments
12.3.1.1. Hematology Analyzers
12.3.1.1.1. Fully-automated Hematology Analyzers
12.3.1.1.2. Semi-automated Hematology Analyzers
12.3.1.2. Flow Cytometers
12.3.1.3. Others
12.3.2. Hematology Consumables
12.3.2.1. Reagents
12.3.2.2. Stains
12.3.2.3. Controls & Calibrators
12.3.2.4. Others
12.4. Market Value Forecast, by End-user, 2023–2031
12.4.1. Diagnostic Laboratories
12.4.2. Hospitals & Clinics
12.4.3. Academic Institutes
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Hematology Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2023–2031
13.3.1. Hematology Instruments
13.3.1.1. Hematology Analyzers
13.3.1.1.1. Fully-automated Hematology Analyzers
13.3.1.1.2. Semi-automated Hematology Analyzers
13.3.1.2. Flow Cytometers
13.3.1.3. Others
13.3.2. Hematology Consumables
13.3.2.1. Reagents
13.3.2.2. Stains
13.3.2.3. Controls & Calibrators
13.3.2.4. Others
13.4. Market Value Forecast, by End-user, 2023–2031
13.4.1. Diagnostic Laboratories
13.4.2. Hospitals & Clinics
13.4.3. Academic Institutes
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Abbott
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Sysmex Corporation
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. F. Hoffmann-La Roche Ltd.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Beckman Coulter, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Bio-Rad Laboratories, Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Siemens Healthineers AG
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Horiba, Ltd.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. HemoCue AB
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Danaher Corporation
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings